Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-23-017407

Head of R&D, CSO gave up 1,134 shares (to pay taxes)

  • Head of R&D, CSO acquired 4,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Head of R&D, CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-06 Shares withheld for taxes : show line 1 in the form −1,134 $157.21 $178,276 66,582 D
2023-03-06 Grant or award : show line 2 in the form +4,500 71,082 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-06 Grant or award : show line 3 in the form Stock Option (right to buy) +27,000 27,000 D
Loading xslF345X03/doc4.xml…